Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02417948
Other study ID # CASE1615
Secondary ID NCI-2015-00481CA
Status Completed
Phase N/A
First received April 13, 2015
Last updated December 2, 2015
Start date April 2015
Est. completion date September 2015

Study information

Verified date December 2015
Source Case Comprehensive Cancer Center
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

This randomized clinical trial uses an educational brochure and online tutorial program to assess sun-protective behavior and skin self-examination among African Americans. Skin cancer is very common among African Americans, with a disproportionately high mortality rate. Providing a brochure and an online educational program about sun-protective behaviors may encourage African Americans to take preventative measures against skin cancer, help improve early skin cancer detection, determine how far the disease has spread, and plan the best treatment.


Description:

PRIMARY OBJECTIVES:

I. To assess whether an educational brochure and online program will increase sun-protective behaviors among African-American patients who present at the general dermatology clinic.

SECONDARY OBJECTIVES:

I. To assess whether the educational brochure and online program will improve skills for skin self-examinations among African-American patients who present at the general dermatology clinic.

OUTLINE: Participants are assigned to 1 of 2 arms.

ARM I: Participants receive a skin cancer educational and preventive brochure distributed by the National Cancer Institute and watch a 30-minute online tutorial video called X-Plain about skin cancer, preventative behaviors, and skin self-examinations.

ARM II: Participants receive an educational brochure as in Arm I.

After completion of study, participants are followed up at 30 days.


Recruitment information / eligibility

Status Completed
Enrollment 143
Est. completion date September 2015
Est. primary completion date September 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Self-identified African-Americans who are literate and fluent in English

Exclusion Criteria:

- Non-African-Americans

- English illiteracy

- non-fluency in English

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Other:
Written Educational Brochure
Receive brochure with skin cancer education and preventative information
Online educational video
Watch 30-minute online tutorial video about skin cancer, preventive behaviors, and skin self-examinations

Locations

Country Name City State
United States Case Comprehensive Cancer Center Cleveland Ohio

Sponsors (2)

Lead Sponsor Collaborator
Case Comprehensive Cancer Center National Cancer Institute (NCI)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in sunscreen use among African-American patients Change in sun-protective behaviors among African-American patients. Measured by sunscreen use. All responses for questions about sun-protective behaviors are on a 5-point Likert scale. Summary scores will be created at baseline and short-term (1 month) follow-up for both control and treatment groups. The outcome variable is a continuous variable. Treatment scores individuals on the intervention group will be compared. T-tests will be used to compare mean scores for sun-protective behaviors between control and treatment groups. Baseline to day 30 No
Primary Change in apparel use when exposed to sun among African-American patients Change in sun-protective behaviors among African-American patients. Measured by apparel use when exposed to sun. All responses for questions about sun-protective behaviors are on a 5-point Likert scale. Summary scores will be created at baseline and short-term (1 month) follow-up for both control and treatment groups. The outcome variable is a continuous variable. Treatment scores individuals on the intervention group will be compared. T-tests will be used to compare mean scores for sun-protective behaviors between control and treatment groups. Baseline to day 30 No
Primary Change in frequency of tanning among African-American patients Change in sun-protective behaviors among African-American patients. Measured by frequency of tanning. All responses for questions about sun-protective behaviors are on a 5-point Likert scale. Summary scores will be created at baseline and short-term (1 month) follow-up for both control and treatment groups. The outcome variable is a continuous variable. Treatment scores individuals on the intervention group will be compared. T-tests will be used to compare mean scores for sun-protective behaviors between control and treatment groups. Baseline to day 30 No
Secondary Change in skin self-examinations among African-American patients as measured by knowledge, behavior and anxiety Analyzed by looking at increase or decrease in skin self-examinations the patients report from pre-intervention to post-intervention. Performance of skin self-examination is measured by knowledge, behavior, and anxiety. Most responses for questions about skin self-examinations are on a 5-point Likert scale, while some are yes/no or true/false. Summary scores will be created at baseline and short-term (1 month) follow-up for both control and treatment groups. The outcome variable is a continuous variable. T-tests will be used to compare mean scores for skin self-examinations between groups. Baseline to day 30 No
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04358276 - Technology-Enabled Activation of Skin Cancer Screening for Stem Cell Transplant Survivors and Their Primary Care Providers, TEACH Study N/A
Completed NCT01242618 - Tissue Engineered Nasal Cartilage for Reconstruction of the Alar Lobule Phase 1
Not yet recruiting NCT06167096 - Effects of Lavender Aromatherapy on Patient Anxiety During Mohs Micrographic Surgery N/A
Recruiting NCT03699995 - MoleMapper, Visiomed, and Confocal Microscopy in Screening Participants for Melanoma N/A
Completed NCT04456140 - Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study Phase 1
Terminated NCT03630601 - Photoacoustic Imaging in Diagnosing Changes in Tumors in Participants With Breast Cancer, Sarcoma, Skin Cancer, or Soft Tissue Malignancy and Healthy Volunteers N/A
Recruiting NCT03543969 - Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma Early Phase 1
Completed NCT00783965 - Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Chest and Back Phase 2
Recruiting NCT04475640 - Cancer Genetic Testing in Ethnic Populations N/A
Active, not recruiting NCT02465060 - Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) Phase 2
Completed NCT03177057 - SMART Project in Preventing Skin Cancer N/A
Completed NCT03290989 - Itch and Pain Characteristics in Skin Carcinomas N/A